Epilepsy Trial, Recruiting NCT07651709 Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT07651709
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with focal or generalized epilepsy, as defined by the International League Against Epilepsy.
  • Women of childbearing age who are 18 years or older, and who are either planning a pregnancy or are in early pregnancy (up to 16 weeks along, confirmed by their last period date or an ultrasound), with a single baby.
  • People who are willing and able to sign a written consent form agreeing to take part.

Who may not be able to join:

  • People who have certain conditions that affect how the body manages bone health, including overactive parathyroid glands, Paget's disease of bone, multiple myeloma, reduced kidney function, serious liver scarring, or an untreated thyroid condition.
  • People who have a history of too much calcium in the blood, kidney stones, or certain diseases that cause inflammation in body tissues (granulomatous diseases).
  • People who have recently used or are currently using certain medications that affect bone, including bisphosphonates, steroid medicines at higher doses for more than a month, or water tablets called loop diuretics within the past year.
  • People whose ultrasound has shown a problem with the baby's development.
  • People with other serious health conditions that the trial doctor considers would make participation unsuitable (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 15215880868

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 January 2035

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Bone metabolisms indicators in offspring; Bone metabolisms indicators in offspring; Bone metabolisms indicators in offspring; Bone metabolisms indicators in offspring; Bone metabolisms indicators in offspring; Bone metabolisms indicators in offspring

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov